Nanobiotix SA

Nanobiotix is a French clinical-stage biotechnology company developing physics-based therapeutic approaches, including injectable nanoparticles intended to enhance local treatment effects when activated by radiotherapy. Its work targets cancers and aims to expand the potential of established radiation treatment through investigational nanomedicine technologies. The company has clinical research and development activities with external partners, and its programs remain subject to regulatory evaluation. Nanobiotix ordinary shares trade on Euronext Paris under NANO, and its American depositary shares trade on Nasdaq under NBTX.